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ABSTRACT
Pneumocystis infection occurs worldwide, and
most individuals test seropositive for Pneumocystis
early in childhood. Little is known about the
epidemiology of this infection in western Europe.
The seroprevalence ofPneumocystis infection in 233
Spanish children was determined in a community
study by immunoblot analysis of sera. The overall
seroprevalence was 73%, with an age-related
increase from 52% at 6 years to 66% at 10 years
and 80% at 13 years. The data indicated a high
seroprevalence of Pneumocystis infection in healthy
Spanish children, thereby demonstrating that this
pathogen is widespread in southern Spain.
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Despite recent advances in our knowledge of
Pneumocystis disease in immunocompromised
individuals, the natural history and epidemiology
ofPneumocystis infection in normal subjects are still
poorly understood. Serological studies have
shown that healthy adults frequently have serum
antibodies to this pathogen [1–3], and that the
primary contact usually occurs during childhood,
with age-related differences in the prevalence rate
being reported [2,4–8]. However, little is known
about the acquisition of Pneumocystis jirovecii
infection in western Europe [4,6,7], and there is
no published information on spread among chil-
dren in the Mediterranean area. This information
would be of particular interest, since P. jirovecii
colonisation rates of 10–40% have been reported in
southern European patients with chronic bronchial
disease [9,10], which suggests wide dissemination
of the organism among the general population in
this area. Therefore, the objective of the present
study was to investigate the seroprevalence of
Pneumocystis infection in Spanish children.
A cross-sectional study was performed with
children aged 6, 10 and 13 years from three rural
villages (Coronil, Pruna and Palmar) located in
Andalucia, Spain. Community doctors obtained
demographic information and serum samples at
the children’s school after informed consent. An
immunoblot assay [11,12] was used to detect Pneu-
mocystis antibodies in serum diluted 1:50. Pneumo-
cystis carinii antigen was obtained from the lungs of
Wistar female rats with dexamethasone-induced
pneumocystosis as described previously [13,14].
Anti-Pneumocystis antibodies were detected with
alkaline phosphatase-conjugated anti-human IgG,
IgA and IgM antibodies (Dako, Glostrup, Den-
mark). An anti-mouse P. carinii monoclonal anti-
body (MAb) (Dako) was used as a positive control.
All immunoblots were examined independently
by two investigators. The presence of an immuno-
reactive band of 120 kDa (the molecular size of the
MAb) was interpreted as a positive result regard-
less of the staining intensity of the band.
Overall, the presence of serum antibodies
against Pneumocystis was detected in 169 (73%)
of 233 children. A significant increase in the
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prevalence of anti-Pneumocystis antibodies with
age was observed, from 52% at 6 years to 66% at
10 years and 80% at 13 years, suggesting that
continuous exposure to Pneumocystis occurs dur-
ing childhood. There were no significant differ-
ences in terms of the gender or place of residence
(Table 1). The study included 12 siblings, for
whom the results of immunoblot analysis were
concordant in ten pairs (both positive in nine
cases, both negative in one case) and discrepant in
the remaining two pairs. Immunoblot analysis
revealed reactivity against numerous Pneumocys-
tis antigens. The banding pattern of sera was
complex and heterogeneous, with bands in
regions at 35–49 kDa, 50 kDa, 51–74 kDa,
75–104 kDa, 105 kDa and 120 kDa. No specific
pattern in terms of age was noted.
Serological tools have proved useful in epide-
miological studies to evaluate the spread of
infection in healthy people [1–3,14], but few
previous studies have focused on children. Using
immunofluorescence techniques, two surveys
conducted in The Netherlands and the USA have
indicated that most healthy children develop
serum antibodies to Pneumocystis before the age
of 4 years [4,5]. Similarly, anti-Pneumocystis anti-
bodies were found by ELISA with a rat-derived
Pneumocystis extract as antigen in 70% of British
and Gambian children aged 8 years [7].
Using human-derived Pneumocystis antigen,
more recent studies in North American and
Danish children have confirmed that most indi-
viduals are exposed to Pneumocystis during the
first year of life, with a seroprevalence rate
ranging from 100% at an age of 2.5 years [2] to
30% in a group aged 1–9 years [6]. Vargas et al.
[8] reported that 85% of a cohort of 74 Chilean
infants developed anti-Pneumocystis serum anti-
bodies by the age of 20 months. However, these
reports included children attending paediatric
health care units or visiting hospitals for other
serological tests. In contrast, the present cross-
sectional survey evaluated a wide community of
233 children aged 6–13 years, which might be
considered a more appropriate population for
appraising seroprevalence in childhood.
One possible limitation of the study might be
the use of rat-derived P. carinii antigen in the
immunoblot assay because of the difficulty in
obtaining P. jirovecii antigen from a human source
in the absence of a reliable method for in-vitro
culture. However, rat-derived Pneumocystis anti-
gen has been shown previously to be useful for
serological analysis of the human immune re-
sponse to Pneumocystis [4,5,7,8,15,16]. Moreover,
the specificity of the serological assay was
improved by using a MAb-positive control that
was cross-reactive between the major surface
glycoprotein of ferret-, mouse-, rat- and human-
derived Pneumocystis [17,18], and by restricting
the positivity criteria to the presence of antibody
against this antigen in serum samples. Consider-
ing other reactivities in the absence of a positive
control does not completely eliminate the possi-
bility of cross-reactivity against non-Pneumocystis
antigens.
An interesting finding of this study was the
high concordance of serological results in the 12
sibling pairs included in the analysis, of which
nine pairs were positive. These data suggest the
possibility of transmission of Pneumocystis infec-
tion between immunocompetent family members,
in agreement with the observation of the trans-
mission of Pneumocystis DNA from a child with
Pneumocystis pneumonia to his mother [19].
An antibody response to multiple Pneumocystis
antigens was detected in most samples. The most
frequent reactivities found in child sera were
bands of 120 kDa, 75–104 kDa and 35–49 kDa.
Similar results have been reported in adults [16].
It was not possible to detect specific age-related
patterns of reactivities, probably because of the
small age differences between the groups. How-
ever, this study demonstrates, for the first time,
widespread and continuous exposure of children
from southern Spain to this pathogen. Further
studies are needed to determine the clinical
significance and epidemiological relevance of
these findings.
Table 1. Seroprevalence of Pneumocystis infection in






6 23 12 (52.1) < 0.001
10 82 54 (65.8)
13 128 103 (80.4)
Sex
Male 125 88 (70.4) 0.47
Female 108 81 (75)
Place of residence
Coronil 127 88 (69.3) 0.35
Palmar 70 55 (78.5)
Pruna 36 26 (72.2)
aChi-square test.
1030 Clinical Microbiology and Infection, Volume 10 Number 11, November 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 1006–1035
ACKNOWLEDGEMENTS
This work was supported in part by the Fifth Framework
Programme of the European Commission (Contract No.
QLK2-2000-01369), the Consejerı´a de Salud de la Junta de
Andalucı´a (Exp. 32 ⁄ 02) and the Thematic Network for Joint
Research G03 ⁄ 90, Spanish Ministry of Health and Consumer
Affairs.
REFERENCES
1. Jameson B. Serology of Pneumocystis carinii. In: Young LS,
ed. Pneumocystis carinii pneumonia, 1st edn. New York:
Dekker, 1984; 97–106.
2. Peglow SL, Smulian AG, Linke MJ et al. Serologic response
to Pneumocystis carinii antigens in health and disease.
J Infect Dis 1990; 161: 296–306.
3. Smulian AG, Sullivan DW, Linke MJ et al. Geographic
variation in the humoral response to Pneumocystis. J Infect
Dis 1993; 167: 1243–1247.
4. Meuwissen JHE, Tauber I, Leeuwenberg ADEM, Beckers
PJA, Sieben M. Parasitologic and serologic observations of
infection with Pneumocystis in humans. J Infect Dis 1977;
136: 43–49.
5. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis
carinii infection: evidence for high prevalence in normal
and immunosuppressed children. Pediatrics 1978; 61: 35–41.
6. Lundgren B, Lebech M, Lind K, Nielsen JO, Lundgren JD.
Antibody response to a major human Pneumocystis carinii
antigen in patients without evidence of immunosuppres-
sion and in patients with suspected atypical pneumonia.
Eur J Clin Microbiol Infect Dis 1993; 12: 105–109.
7. Wakefield AE, Stewart TJ, Moxon ER, Marsh K, Hopkin
JM. Infection with Pneumocystis carinii is prevalent in
healthy Gambian children. Trans R Soc Trop Med Hyg 1990;
84: 800–802.
8. Vargas SL, Hughes WT, Santolaya ME et al. Search for
primary infection by Pneumocystis carinii in a cohort of
normal healthy children. Clin Infect Dis 2001; 32: 855–861.
9. Caldero´n EJ, Regordan C, Medrano FJ, Ollero M, Varela
JM. Pneumocystis carinii infection in patients with chronic
bronchial disease. Lancet 1996; 347: 977.
10. Sing A, Roggenkamp A, Autenrieth IB, Heesemann J.
Pneumocystis carinii carriage in immunocompetent patients
with primary pulmonary disorders as detected by single
or nested PCR. J Clin Microbiol 1999; 37: 3409–3410.
11. Laemmli UK. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 1970;
227: 680–685.
12. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer
of proteins from polyacrylamide gels to nitrocellulose
sheets: procedure and some applications. Proc Natl Acad
Sci USA 1979; 76: 4350–4354.
13. Aliouat EM, Martinez A, Jime´nez E et al. Development of
pneumocystosis animal models: corticosteroid-treated
Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol
1997; 44(suppl): 41S–42S.
14. Medrano FJ, Respaldiza N, Medrano A et al. Seropreva-
lence of Pneumocystis human infection in southern Spain.
J Eukaryot Microbiol 2003; 50(suppl): 649–650.
15. Kohout E, Post C, Azadeh B, Dutz W, Banderizadeh B,
Kadivar D. Immunoglobulin levels in infantile pneumo-
cystosis. J Clin Pathol 1972; 25: 135–140.
16. Chatterton JMW, Joss AWL, Pennington TH, Do H-Y.
Usefulness of rat derived antigen in the serodiagnosis of
Pneumocystis carinii infection. J Med Microbiol 1999; 48: 681–
687.
17. Gigliotti F. Host species-specific antigenic variation of a
mannosylated surface glycoprotein of Pneumocystis carinii.
J Infect Dis 1992; 165: 329–336.
18. Walzer PD, Kim CK, Cushion MT. Pneumocystis carinii. In:
Walzer PD, Genta RM, eds. Parasitic infections in the com-
promised host, 1st edn. New York: Dekker, 1989; 83–178.
19. Vargas SL, Ponce CA, Giglotti F et al. Transmission of
Pneumocystis carinii DNA from a patient with P. carinii
pneumonia to immunocompetent contact health care
workers. J Clin Microbiol 2000; 38: 1536–1538.
RESEARCH NOTE
Salmonella Enteritidis in Bosnia and
Herzegovina
S. Uzunovic-Kamberovic
Laboratory for Sanitary and Clinical Microbio-
logy, Canton Institute Public Health, Zenica,
Bosnia and Herzegovina
ABSTRACT
A comprehensive retrospective analysis of human
Salmonella Enteritidis isolates in the Zenica-Doboj
Canton of Bosnia and Herzegovina was conduc-
ted by inquiry and questionnaire. In the period
1998–2000, 299 isolates of Salmonella spp. were
recorded, of which S. Enteritidis accounted for
74.2%. The isolation rate of S. Enteritidis
increased during this period, from 12.7 to 25.5
isolates ⁄ year ⁄ 100 000 population. Isolates were
obtained all year round, mostly from sporadic
cases of infection or limited family outbreaks.
Home-made food was identified as the most
important source of infection, being implicated
in 81% of outbreaks and 81.7% of cases of
sporadic infection.
Keywords Bosnia and Herzegovina, food-borne
infection, Salmonella Enteritidis
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